BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26067584)

  • 21. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
    Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
    Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle.
    Hutchins-Wiese HL; Li Y; Hannon K; Watkins BA
    J Nutr Biochem; 2012 Aug; 23(8):986-93. PubMed ID: 22051448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol.
    Petrenko AB; Yamazaki M; Sakimura K; Kano M; Baba H
    Behav Brain Res; 2014 Sep; 271():51-8. PubMed ID: 24906199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
    Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
    Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
    Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
    Lafourcade M; Elezgarai I; Mato S; Bakiri Y; Grandes P; Manzoni OJ
    PLoS One; 2007 Aug; 2(8):e709. PubMed ID: 17684555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures.
    Sugaya Y; Yamazaki M; Uchigashima M; Kobayashi K; Watanabe M; Sakimura K; Kano M
    Cell Rep; 2016 Aug; 16(5):1405-1415. PubMed ID: 27452464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
    Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
    Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.
    Wyrofsky RR; Reyes BAS; Yu D; Kirby LG; Van Bockstaele EJ
    Eur J Neurosci; 2018 Sep; 48(5):2118-2138. PubMed ID: 30103253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.
    Gamelin FX; Aucouturier J; Iannotti FA; Piscitelli F; Mazzarella E; Aveta T; Leriche M; Dupont E; Cieniewski-Bernard C; Montel V; Bastide B; Di Marzo V; Heyman E
    J Physiol Biochem; 2016 Jun; 72(2):183-99. PubMed ID: 26880264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
    Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
    Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain.
    Ramírez-López A; Pastor A; de la Torre R; La Porta C; Ozaita A; Cabañero D; Maldonado R
    Eur J Pain; 2021 Jul; 25(6):1316-1328. PubMed ID: 33619843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
    Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
    Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
    Mecha M; Feliú A; Carrillo-Salinas FJ; Rueda-Zubiaurre A; Ortega-Gutiérrez S; de Sola RG; Guaza C
    Brain Behav Immun; 2015 Oct; 49():233-45. PubMed ID: 26086345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
    Schloss MJ; Horckmans M; Guillamat-Prats R; Hering D; Lauer E; Lenglet S; Weber C; Thomas A; Steffens S
    Cardiovasc Res; 2019 Mar; 115(3):602-613. PubMed ID: 30295758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
    Kim J; Watkins BA
    J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.